Free Trial
OTCMKTS:JUSHF

Jushi 8/5/2025 Earnings Report

Jushi logo
$0.63 -0.04 (-5.26%)
As of 09/12/2025 03:54 PM Eastern

Jushi EPS Results

Actual EPS
-$0.06
Consensus EPS
-$0.06
Beat/Miss
Met Expectations
One Year Ago EPS
N/A

Jushi Revenue Results

Actual Revenue
$65.05 million
Expected Revenue
$64.67 million
Beat/Miss
Beat by +$379.00 thousand
YoY Revenue Growth
N/A

Jushi Announcement Details

Quarter
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Jushi's next earnings date is estimated for Thursday, November 6, 2025, based on past reporting schedules.

Conference Call Resources

Jushi Earnings Headlines

Warren Buffett Issues Cryptic Warning on U.S. Dollar
Imagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA or Bitcoin, but by owning a simple index fund. It sounds impossible. Yet it happened – just a short time ago. Now a legendary figure says: "Brace yourselves. It's about to happen here, in America. But fair warning – it could be the worst thing that ever happens to you." This story has received little coverage in the press. But if history repeats, it could bump tens of millions of Americans into a 7-figure net worth practically overnight.tc pixel
See More Jushi Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Jushi? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Jushi and other key companies, straight to your email.

About Jushi

Jushi (OTCMKTS:JUSHF) is a vertically integrated cannabis company engaged in the cultivation, manufacturing and sale of cannabis products across the United States. The company operates cultivation and processing facilities that support a diversified portfolio of consumer brands, serving both medical and adult-use markets. Through its in-house operations, Jushi produces hand-trimmed flower, pre-rolls, vaporizers, concentrates, edibles and topicals.

Jushi’s brand lineup includes Foray, Levia and Beboe, each designed to address distinct consumer preferences and consumption occasions. Foray focuses on more traditional flower and pre-roll offerings, while Levia was developed to deliver precision dosing through measured infusions. Beboe, known for its sleek packaging and high-potency formulations, targets the premium segment of the market. The company’s cultivation processes emphasize quality control and consistency, leveraging data and analytics to optimize yields and cannabinoid profiles.

The company’s retail footprint extends across multiple states, including key markets such as Pennsylvania, Connecticut, Ohio, California and Florida, among others. Jushi expanded its geographic presence in mid-2020 through the acquisition of PharmaCann, adding operational dispensaries and production assets in several new jurisdictions. This strategic move broadened Jushi’s market access, allowing the company to serve a wider patient and adult-use consumer base under state regulatory frameworks.

Founded in 2017 and led by Chief Executive Officer Jason Vedadi, Jushi emphasizes a culture of compliance and innovation. The executive team combines expertise in real estate, retail operations and consumer products to drive growth and operational efficiency. As the legal cannabis industry continues to evolve, Jushi positions itself to capitalize on changing regulations and increasing consumer acceptance.

View Jushi Profile

More Earnings Resources from MarketBeat